<?xml version='1.0' encoding='UTF-8' ?>
<ec-patent-document file='EC_SP17008187_20180329.xml' country='EC' doc-number='SP17008187' kind='A' date-published='20180329' lang='ES' date-produced='20190116'>
<bibliographic-data id='bibl' doc-number='SP17008187' country='EC' lang='es'>
<publication-reference><document-id ><country>EC</country><doc-number>SP17008187</doc-number><kind>A</kind><date>20180329</date></document-id></publication-reference>
<classification-ipcr><classification-ipc sequence='1'><section> </section><class> </class><subclass> </subclass><main-group> </main-group><subgroup> </subgroup><edition> </edition><ipc-version-indicator><date> </date></ipc-version-indicator><classification-level>A61K9/20_A61K31/45</classification-level><symbol-position> </symbol-position><classification-value> </classification-value></classification-ipc></classification-ipcr>
<application-reference> <document-id><country>EC</country><doc-number>IEPI20178187</doc-number><date>20170210</date></document-id></application-reference>
<priority-claims>
<priority-claim sequence='1' kind='National'><doc-number>62/021,271</doc-number><date>20140714</date><country>US</country></priority-claim>
</priority-claims>
<parties><applicants>
<applicant sequence='1' designation='all' app-type='applicant'><addressbook><name>NOVARTIS AG</name><address><street>CH-4002 BASEL, SWITZERLAND</street><country>CH</country></address></addressbook></applicant>
</applicants>
<inventors>
<inventor sequence='1' designation='all'><addressbook><name>Peggy QUINTON</name><address><street>c/o Novartis Pharma AG  Postfach CH-4002 Basel  Switzerland</street><country>FR</country></address></addressbook></inventor>
<inventor sequence='2' designation='all'><addressbook><name>Stefania BEATO</name><address><street>c/o Novartis Pharma AG  Postfach CH-4002 Basel Switzerland</street><country>IT</country></address></addressbook></inventor>
</inventors><agents>
<agent sequence='1' rep-type='agent'><addressbook><name>Esteban Riofrio Correa </name><address><street>Av. 12 de Octubre y Abrahan Lincoln</street><country>EC</country></address></addressbook></agent>
</agents></parties>
<invention-title lang='es'>FORMAS DE DOSIFICACIÓN FARMACÉUTICA</invention-title>
</bibliographic-data>
<abstract lang='es'>La presente invención se refiere a formas de dosificación farmacéutica para administración oral que comprenden el fármaco 4-[(5R)-6,7-dihidro-5H-pirrolo[1,2-c]imidazol-5-il]-3-fluorobenzonitrilo o cualquier sal farmacéuticamente aceptable del mismo y a procesos para producir dichas formas sólidas de dosificación farmacéutica.
</abstract>
</ec-patent-document>
